MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 1 signal for MADRIGAL PHARMACEUTICALS, INC.. Most notable: 2026-08-12: Filed 8-K disclosing director or officer change. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
- Large insider saleTaub Rebecca (director) sold $1.1M of stock
- Large insider saleFRIEDMAN PAUL A (director) sold $1.3M of stock
- Large insider saleFRIEDMAN PAUL A (director) sold $1.3M of stock
- Large insider saleFRIEDMAN PAUL A (director) sold $1.3M of stock
- Large insider saleFRIEDMAN PAUL A (director) sold $1.3M of stock
- Large insider saleFRIEDMAN PAUL A (director) sold $1.0M of stock
- Large insider saleFRIEDMAN PAUL A (director) sold $1.0M of stock
- Large insider saleTaub Rebecca (director) sold $1.1M of stock
- Large insider saleTaub Rebecca (director) sold $1.1M of stock
- Material 8-K filingFiled 8-K disclosing director or officer change
- Large insider saleFRIEDMAN PAUL A (director) sold $4.0M of stock
- Large insider saleFRIEDMAN PAUL A (director) sold $4.0M of stock
- Large insider saleFRIEDMAN PAUL A (director) sold $3.1M of stock
- Large insider saleFRIEDMAN PAUL A (director) sold $3.1M of stock
- Large insider saleFRIEDMAN PAUL A (director) sold $2.4M of stock
- Large insider saleFRIEDMAN PAUL A (director) sold $2.8M of stock
- Large insider saleTaub Rebecca (director) sold $2.4M of stock
- Large insider saleTaub Rebecca (director) sold $2.6M of stock
- Large insider saleFRIEDMAN PAUL A (director) sold $2.8M of stock
- Large insider saleTaub Rebecca (director) sold $2.6M of stock
- Large insider saleTaub Rebecca (director) sold $2.1M of stock
- Large insider saleTaub Rebecca (director) sold $2.1M of stock
- Large insider saleTaub Rebecca (director) sold $1.7M of stock
- Large insider saleTaub Rebecca (director) sold $1.7M of stock
- Large insider saleSibold William John (director) sold $1.4M of stock
- Large insider saleBATE KENNETH (director) sold $1.4M of stock
- Large insider saleBATE KENNETH (director) sold $1.6M of stock
- Large insider saleBATE KENNETH (director) sold $1.6M of stock
- Large insider saleBATE KENNETH (director) sold $1.0M of stock
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-09-11 | Sibold William John | director | S | 120 | 546.38 | $65,565 |
| 2026-09-11 | Sibold William John | director | S | 761 | 544.83 | $414,616 |
| 2026-09-11 | Sibold William John | director | S | 1,539 | 544.02 | $837,253 |
| 2026-09-11 | Sibold William John | director | S | 1,202 | 542.6 | $652,209 |
| 2026-09-11 | Sibold William John | director | S | 368 | 541.64 | $199,324 |
| 2026-09-11 | Sibold William John | director | S | 687 | 540.59 | $371,382 |
| 2026-09-11 | Sibold William John | director | S | 160 | 537.62 | $86,019 |
| 2026-09-11 | Sibold William John | director | S | 218 | 535.94 | $116,836 |
| 2026-09-11 | Sibold William John | director | S | 106 | 534.06 | $56,611 |
| 2026-09-11 | Sibold William John | director | S | 60 | 533.09 | $31,985 |
| 2026-09-09 | Sibold William John | director | S | 160 | 542.55 | $86,808 |
| 2026-09-09 | Sibold William John | director | S | 362 | 541.65 | $196,079 |
| 2026-09-09 | Sibold William John | director | S | 505 | 540.19 | $272,796 |
| 2026-09-09 | Sibold William John | director | S | 215 | 539.03 | $115,891 |
| 2026-09-09 | Sibold William John | director | S | 520 | 538.3 | $279,914 |
| 2026-09-09 | Sibold William John | director | S | 640 | 537.17 | $343,791 |
| 2026-09-09 | Sibold William John | director | S | 1,040 | 536.11 | $557,557 |
| 2026-09-09 | Sibold William John | director | S | 644 | 535.27 | $344,715 |
| 2026-09-09 | Sibold William John | director | S | 396 | 534.2 | $211,542 |
| 2026-09-09 | Sibold William John | director | S | 512 | 533.09 | $272,944 |
| 2026-09-09 | Sibold William John | director | S | 368 | 531.99 | $195,772 |
| 2026-09-09 | Sibold William John | director | S | 522 | 530.23 | $276,781 |
| 2026-09-09 | Sibold William John | director | S | 347 | 529.27 | $183,656 |
| 2026-09-09 | Sibold William John | director | S | 131 | 527.88 | $69,152 |
| 2026-08-17 | Kelley Shannon T | officer | S | 664 | 514.97 | $341,940 |
| 2026-08-15 | REED JOHN C | director | A | 647 | 0 | $0 |
| 2026-07-20 | Sibold William John | director | S | 140 | 542.75 | $75,984 |
| 2026-07-20 | Sibold William John | director | S | 110 | 543.79 | $59,817 |
| 2026-07-20 | Sibold William John | director | S | 545 | 544.71 | $296,869 |
| 2026-07-20 | Sibold William John | director | S | 275 | 545.71 | $150,070 |
| 2026-07-20 | Sibold William John | director | S | 269 | 547.08 | $147,164 |
| 2026-07-20 | Sibold William John | director | S | 680 | 547.7 | $372,435 |
| 2026-07-20 | Sibold William John | director | S | 47 | 548.87 | $25,797 |
| 2026-07-20 | Sibold William John | director | S | 153 | 550.01 | $84,152 |
| 2026-07-20 | Sibold William John | director | S | 1 | 550.72 | $551 |
| 2026-07-20 | Sibold William John | director | S | 280 | 555.05 | $155,414 |
| 2026-07-17 | Sibold William John | director | M | 50,000 | — | — |
| 2026-06-17 | Taub Rebecca | director | A | 454 | 0 | $0 |
| 2026-06-17 | Levy Richard S | director | A | 454 | 0 | $0 |
| 2026-06-17 | FOUSE JACQUALYN A | director | A | 454 | 0 | $0 |
| 2026-06-17 | Daly James M | director | A | 454 | 0 | $0 |
| 2026-06-17 | Brennan Daniel J. | director | A | 404 | 0 | $0 |
| 2026-06-17 | Baker Brothers Life Sciences LP | director | A | 908 | 0 | $0 |
| 2026-06-17 | Baker Brothers Life Sciences LP | director | A | 908 | 0 | $0 |
| 2026-06-17 | Taub Rebecca | director | A | 454 | 0 | $0 |
| 2026-06-17 | Levy Richard S | director | A | 454 | 0 | $0 |
| 2026-06-17 | FOUSE JACQUALYN A | director | A | 454 | 0 | $0 |
| 2026-06-17 | Daly James M | director | A | 454 | 0 | $0 |
| 2026-06-17 | Brennan Daniel J. | director | A | 404 | 0 | $0 |
| 2026-06-17 | BAKER BROS. ADVISORS LP; 667, L.P.; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP; BAKER FELIX; BAKER JULIAN | director | A | 908 | 0 | $0 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.